AMENDMENTLicense Agreement • November 9th, 2012 • Biotime Inc • Biological products, (no disgnostic substances) • Utah
This Amendment (“AMENDMENT”) is made and is effective as of May 9, 2006, by and between Glycosan BioSystems, Inc. (“LICENSEE”), having an address at PO Box 2321, Park City, Utah 84060 and the University of Utah Research Foundation (“LICENSOR”), having an address at 615 Arapeen Drive, Suite 310, Salt Lake City, Utah, 84108. LICENSEE and the LICENSOR are referred to herein collectively as “PARTIES”.
AMENDMENT TO SHARE EXCHANGE AND CONTRIBUTION AGREEMENTShare Exchange and Contribution Agreement • November 9th, 2012 • Biotime Inc • Biological products, (no disgnostic substances)
This Amendment is entered into as of September 28, 2012 and amends that certain Share Exchange and Contribution Agreement (the Agreement) among LifeMap Sciences, Inc., a California corporation (the Company) and Alfred D. Kingsley and Greenway Partners, L.P. (collectively, Investor).
SHARE PURCHASE AGREEMENT BY AND BETWEENShare Purchase Agreement • November 9th, 2012 • Biotime Inc • Biological products, (no disgnostic substances)
CELL CURE NEUROSCIENCES LTD. a company organized under the laws of the State of Israel, registered under number 51-375239-4 with offices at Kiryat Hadassah, Jerusalem 91121, Israel (the “Company”); and
